期刊文献+

氯胺酮超前镇痛对腹腔镜胆囊切除术后疼痛的临床观察

Preventive Analgesic Effect of Preoperative Ketamine in Relieving Postoperative Pain after Laparoscopic Cholecystectomy
在线阅读 下载PDF
导出
摘要 目的探讨氯胺酮在腹腔镜胆囊切除术后的超前镇痛作用。方法将2006年7~8月,40例择期腹腔镜胆囊切除术按随机数字表法分为2组(每组20例):氯胺酮组和对照组。对术后1、2、4、6、12h及术后1、2、3d切口痛及非切口痛分别进行VAS镇痛评分和术后镇静评分,记录术后不良反应及术后止痛药的需求情况。结果术后非切口痛及切口痛,氯胺酮组VAS评分较对照组显著降低(F=22.805,P=0.000;F=18.109,P=0.000)。术后恶心、呕吐发生率氯胺酮组(55%)和对照组(60%)相比无明显差异(P=1.000);术后需要止痛药氯胺酮组3例,对照组9例,2组无统计学差异(P=0.082)。结论在腹腔镜胆囊切除手术前应用氯胺酮能减轻术后疼痛,具有超前镇痛作用,但不能降低术后恶心、呕吐发生率。 Objective To investigate the effects of ketamine in relieving postoperative pain after laparoscopic cholecystectomy (LC). Methods Forty patients undergoing selective LC from July to August 2006 were randomly divided into ketamine group and control group, with 20 patients in each group. Incision pain and non- incision pain was assessed at 1,2,4,6,12,24 h and once each day for the first 3 days postoperatively with visual analogue pain scale (VAS) and sedation scale. Adverse effects and analgesic requirements were recorded, Results Patients in ketamine group had significantly lower scores in incision pain and non-incision pain compared with those of control group (F = 22. 805, P = 0. 000; F = 18. 109, P = 0,000). Incidence of postoperative nausea and vomiting was not significantly different (P = 1. 000) between ketamine (55%) and control group (60%). No significant difference was noticed in analgesic requirements between ketamine group (3 cases) and control group (9 cases) (P = 0. 082). Conclusions Preoperative administration of ketamine significantly improves postoperative analgesia after laparoscopic cholecystectomy, but does not reduce the incidence of postoperative nausea and vomiting.
出处 《中国微创外科杂志》 CSCD 2007年第8期782-784,共3页 Chinese Journal of Minimally Invasive Surgery
关键词 腹腔镜胆囊切除术 氯胺酮 超前镇痛 Laparoscopic cholecystectomy Ketamine Preventive analgesia
  • 相关文献

参考文献10

二级参考文献45

  • 1黄坤厚 张新宇 等.内毒素休克鼠模型探索[J].基础医学与临床,1994,14:70-70.
  • 2Gottrup H. Differential effects of systemically administered ketamine and lignocaine on dynamic and stati hyperalgesia induced by intradermal capsaicin in humans[l].Anaesth,2000;84(2):155.
  • 3Dennis SG.The formalin test:A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats[J]. Pain, 1977;4(1): 16.
  • 4Stankux SJ, Dlugopolski M Packer. Management of herpes zoster (shingles) and post-therapetic neuralgia [J]. Am Farn Physician, 2000;61(8):2437.
  • 5Robert H. Neurogenic hyperalgesia:Psychophysical studies of underlying mechanisms[J]. J of Neurophysiology,1991;66(1):193.
  • 6Fuchs PN, PappagaUo M, Meyer R. Topical EMLA pretreatment fails to decrease the pain induced by 1% topical capsaicin [J ] .Pain, 1999;80(3):637.
  • 7Koppert W, Ostermeier N, Sittl R,et al.Low-dose lignocaine reduces secondary hyperalgesia by a central mode of action[J].Pain, 2000;85(1-2):2217.
  • 8Gottrup H.Differential effects of systemically administered ketamine and lignocaine on dynamic and stati hyperalgesia induced by intradermal capsaicin in humans[J].Anaesth,2000;84(2):155.
  • 9Dennis SG.The formalin test:A quantitative study of the analgesic effects of morphine,meperidine,and brain stem stimulation in rats and cats[J].Pain,1977;4(1):16.
  • 10Stankux SJ,Dlugopolski M Packer.Management of herpes zoster (shingles) and post-therapetic neuralgia [J].Am Fam Physician,2000;61(8):2437.

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部